Skip to main content
SpringerLink
Log in

Retinoid Embryopathy

  • Living reference work entry
  • First Online:
Atlas of Genetic Diagnosis and Counseling

  • 153 Accesses

Abstract

Oral retinoids, isotretinoin (Accutane), and etretinate, uniquely effective in the treatment for severe cystic and keratinization disorders, are potent human teratogens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Abroms, L., Maibach, E., Lyon-Daniel, K., et al. (2006). What is the best approach to reducing birth defects associated with isotretinoin? PLoS Medicine, 3, e483.

    Article  PubMed  PubMed Central  Google Scholar 

  • Altman, E. M. (2014). Isotretinoin and pregnancy prevention: Do we need to take a long, hard look at ourselves? JAMA Dermatology, 150, 361–362.

    Article  PubMed  Google Scholar 

  • Atanackovic, G., & Koren, G. (1999a). Fetal exposure to oral isotretinoin: Failure to comply with the Pregnancy Prevention Program. Canadian Medical Association Journal, 160, 1719–1720.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Atanackovic, G., & Koren, G. (1999b). Young women taking isotretinoin still conceive. Role of physicians in preventing disaster. Canadian Family Physician, 45, 289–292.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Braun, J. T., Franciosi, R. A., Mastri, A. R., et al. (1984). Isotretinoin dysmorphic syndrome. Lancet, 1, 506–507.

    Article  CAS  PubMed  Google Scholar 

  • Brinker, A., Trontell, A., & Beitz, J. (2002). Pregnancy and pregnancy rates in association with isotretinoin (Accutane). Journal of the American Academy of Dermatology, 47, 798–799.

    Article  PubMed  Google Scholar 

  • Chan, A., Hanna, M., Abbott, M., et al. (1996). Oral retinoids and pregnancy. The Medical Journal of Australia, 165, 164–167.

    CAS  PubMed  Google Scholar 

  • Choi, J. S., Koren, G., & Nulman, I. (2013). Pregnancy and isotretinoin therapy. Canadian Medical Association Journal, 185, 411–413.

    Article  PubMed  PubMed Central  Google Scholar 

  • Collins, M.-K., Moreau, J. F., Opel, D., et al. (2014). Compliance with pregnancy prevention measures during isotretinoin therapy. Journal of American Academy of Dermatology, 70, 55–59.

    Article  Google Scholar 

  • Crijns, H. J. M. J., Staus, S. M., Gispen-de Wied, C. H., et al. (2011). Compliance with pregnancy prevention programs of isotretinoin in Europe: A systemic review. British Journal of Dermatology, 164, 238–244.

    Article  CAS  PubMed  Google Scholar 

  • Dai, W. S., Hsu, M. A., & Itri, L. M. (1989). Safety of pregnancy after discontinuation of isotretinoin. Archives of Dermatology, 125, 362–365.

    Article  CAS  PubMed  Google Scholar 

  • de la Cruz, E., Sun, S., Vangvanichyakorn, K., et al. (1984). Multiple congenital malformations associated with maternal isotretinoin therapy. Pediatrics, 74, 428–430.

    PubMed  Google Scholar 

  • Ellis, C. N., & Krach, K. J. (2001). Uses and complications of isotretinoin therapy. Journal of the American Academy of Dermatology, 45, S150–S157.

    Article  CAS  PubMed  Google Scholar 

  • Fernhoff, P. M., & Lammer, E. J. (1984). Craniofacial features of isotretinoin embryopathy. Journal of Pediatrics, 105, 595–597.

    Article  CAS  PubMed  Google Scholar 

  • Goldsmith, L. A., Bolognia, J. L., Callen, J. P., et al. (2004). American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: Summary and recommendations. Journal of the American Academy of Dermatology, 50, 900–906.

    Article  PubMed  Google Scholar 

  • Henry, D., Dormuth, C., Winquist, B., et al. (2016). Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy. Canadian Medical Association Journal, 188, 723–730.

    Article  PubMed  PubMed Central  Google Scholar 

  • Holmes, S. C., Bankowska, U., & Mackie, R. M. (1998). The prescription of isotretinoin to women: Is every precaution taken? British Journal of Dermatology, 138, 450–455.

    Article  CAS  PubMed  Google Scholar 

  • Jahn, A. F., & Ganti, K. (1987). Major auricular malformations due to Accutane (isotretinoin). Laryngoscope, 97, 832–835.

    Article  CAS  PubMed  Google Scholar 

  • Koren, G., & Pastuszak, A. (1997). How to ensure fetal safety when mothers use isotretinoin (Accutane). Canadian Family Physician, 43, 216–219.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lammer, E. J., Schunior, A., Hayes, A. M., et al. (1988). Isotretinoin dose and teratogenicity. Lancet, 2, 503–504.

    Article  CAS  PubMed  Google Scholar 

  • Lancaster, P. A. (1988). Teratogenicity of isotretinoin. Lancet, 2, 1254–1255.

    Article  CAS  PubMed  Google Scholar 

  • Mitchell, A. A., & Van Bennekom, C. M. (2003). Accutane and pregnancy. Journal of the American Academy of Dermatology, 49, 1201–1202.

    Article  PubMed  Google Scholar 

  • Mitchell, A. A., Van Bennekom, C. M., & Louik, C. (1995). A pregnancy-prevention program in women of childbearing age receiving isotretinoin. The New England Journal of Medicine, 333, 101–106.

    Article  CAS  PubMed  Google Scholar 

  • Panchaud, A., Csajka, C., Merlob, P., et al. (2012). Pregnancy outcome following exposure to topical retinoids: A multicenter prospective study. Journal of Clinical Pharmacology, 52, 1844–1851.

    Article  CAS  PubMed  Google Scholar 

  • Pastuszak, A., & Koren, G. (1993). The retinoid pregnancy prevention program. In G. Koren (Ed.), Retinoids in clinical practice. The risk-benefit ratio (pp. 147–175). New York: Marcel Dekker.

    Google Scholar 

  • Pastuszak, A., Koren, G., & Rieder, M. J. (1994). Use of the retinoid pregnancy prevention program in Canada: Patterns of contraception use in women treated with isotretinoin and etretinate. Reproductive Toxicology, 8, 63–68.

    Article  CAS  PubMed  Google Scholar 

  • Perlman, S. E., Leach, E. E., Dominguez, L., et al. (2001). Be smart, be safe, be sure. The revised Pregnancy Prevention Program for women on isotretinoin. Journal of Reproductive Medicine, 46, 179–185.

    CAS  PubMed  Google Scholar 

  • Rademaker, M. (2010). Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin. Australasian Journal of Dermatology, 51, 248–253.

    Article  PubMed  Google Scholar 

  • Rizzo, R., Lammer, E. J., Parano, E., et al. (1991). Limb reduction defects in humans associated with prenatal isotretinoin exposure. Teratology, 44, 599–604.

    Article  CAS  PubMed  Google Scholar 

  • Sarici, D., Akin, M. A., Kurtoglu, S., et al. (2012). Asymmetric crying face in a newborn with isotretinoin embryopathy. Pediatric Dermatology, 30, e289–e290.

    Article  PubMed  Google Scholar 

  • Shear, N. H. (1999). Oral isotretinoin: Prescribers beware. Canadian Medical Association Journal, 160, 1723–1724.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Stashower, M. E. (2003). Pregnancy rates associated with isotretinoin (Accutane) and the FDA. Journal of the American Academy of Dermatology, 49, 1202–1203.

    Article  PubMed  Google Scholar 

  • Strauss, J. S., Cunningham, W. J., Leyden, J. J., et al. (1988). Isotretinoin and teratogenicity. Journal of the American Academy of Dermatology, 19, 353–354.

    Article  CAS  PubMed  Google Scholar 

  • Werner, C. A., Papic, M. J., Ferris, L. K., et al. (2014). Women’s experiences with isotretinoin risk reduction counseling. JAMA Dermatology, 150, 366–371.

    Article  PubMed  Google Scholar 

  • Zomerdijk, I. M., Ruiter, R., Houweling, L. M. A., et al. (2014). Isotretinoin exposure during pregnancy: A population-based study in The Netherlands. BMJ Open, 4, 1–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Genetics, Shriners Hospitals for Children, Shreveport, LA, USA

    Harold Chen

  2. Perinatal and Clinical Genetics, Department of Pediatrics, LSU Health Sciences Center, 1501 Kings Highway, Shreveport, LA, 71130, USA

    Harold Chen

Authors
  1. Harold Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Harold Chen .

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media LLC

About this entry

Cite this entry

Chen, H. (2016). Retinoid Embryopathy. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6430-3_201-2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6430-3_201-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-6430-3

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics

Search

Navigation